Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dapiglutide

DREAM

Zealand Pharma · Phase 2 · Active, not recruiting · Enrollment 54

NCT05788601

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Placebo (4 mg and 6 mg)n/rn/rn/rn/r
4 mg dapiglutiden/rn/rn/rn/r
6 mg dapiglutiden/rn/rn/rn/r

Not shown

  • Placebo (4 mg and 6 mg): endpoint not reported
  • 4 mg dapiglutide: endpoint not reported
  • 6 mg dapiglutide: endpoint not reported